secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcellx, Inc. (ACLX)
CIK:        0001786205
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001193125-22-281337
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcellx overstates R&D expense by $6.3M in Q1 2022, $7.7M in H1 2022; prior financials non-reliable
--------------------------------------------------------------------------------

- Audit Committee concludes Q1 and Q2 2022 financials no longer reliable due to R&D expense accounting errors.
- R&D expense overstated by $6.3M in Q1 2022 and $7.7M in first half of 2022; no impact on cash or cash flows.
- Material weakness in internal control over financial reporting related to R&D expense accounting.
- Company to file amended Form 10-Q/As for Q1 and Q2 2022, expects to file concurrently with Q3 2022 10-Q.
- Cash position unchanged: $210.9M as of March 31, 2022 and $307.0M as of June 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1786205/000119312522281337/0001193125-22-281337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1786205/000119312522281337/d421011d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-281337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer